BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 34406812)

  • 21. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
    Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
    Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].
    Öcal DN; Dolapçı İ; Gençtürk Z; Tekeli A
    Mikrobiyol Bul; 2017 Jul; 51(3):220-235. PubMed ID: 28929959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002).
    Biedenbach DJ; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):59-69. PubMed ID: 15380279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012-2019.
    Li M; Du M; Li H; Liu D; Liu Y
    Infect Med (Beijing); 2022 Mar; 1(1):23-30. PubMed ID: 38074981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal bloodstream infections in a pediatric hospital in Vietnam: a cohort study.
    Kruse AY; Thieu Chuong do H; Phuong CN; Duc T; Graff Stensballe L; Prag J; Kurtzhals J; Greisen G; Pedersen FK
    J Trop Pediatr; 2013 Dec; 59(6):483-8. PubMed ID: 23868576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofilm formation by clinical isolates and the implications in chronic infections.
    Sanchez CJ; Mende K; Beckius ML; Akers KS; Romano DR; Wenke JC; Murray CK
    BMC Infect Dis; 2013 Jan; 13():47. PubMed ID: 23356488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive Factors for Gram-negative Versus Gram-positive Bloodstream Infections in Children With Cancer.
    Sfetsiori AE; Doganis D; Doudoulakakis A; Spyridis N; Pourtsidis A; Servitzoglou M; Nikita M; Papachristidou S; Magkou E; Dana H; Lebessi E; Kosmidis H; Baka M; Tsolia M
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e368-e373. PubMed ID: 34310469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria.
    Thaden JT; Park LP; Maskarinec SA; Ruffin F; Fowler VG; van Duin D
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bloodstream infections among human immunodeficiency virus-infected adult patients: epidemiology and risk factors for mortality.
    Ortega M; Almela M; Soriano A; Marco F; Martínez JA; Muñoz A; Peñarroja G; Mensa J
    Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):969-76. PubMed ID: 18449581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency of isolation and antimicrobial susceptibility of bacteria isolated from bloodstream infections at Children's Medical Center, Tehran, Iran, 1996-2000.
    Mamishi S; Pourakbari B; Ashtiani MH; Hashemi FB
    Int J Antimicrob Agents; 2005 Nov; 26(5):373-9. PubMed ID: 16213124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of epidemiological, clinical and microbiological characteristics of bloodstream infection in children with solid tumours and haematological malignancies.
    Garrido MM; Garrido RQ; Cunha TN; Ehrlich S; Martins IS
    Epidemiol Infect; 2019 Nov; 147():e298. PubMed ID: 31699182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial profile, antimicrobial susceptibility patterns, and associated factors among bloodstream infection suspected patients attending Arba Minch General Hospital, Ethiopia.
    Birru M; Woldemariam M; Manilal A; Aklilu A; Tsalla T; Mitiku A; Gezmu T
    Sci Rep; 2021 Aug; 11(1):15882. PubMed ID: 34354138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiling of bacterial bloodstream infections in hematological and oncological patients based on a comparative survival analysis.
    Weber S; Magh A; Hogardt M; Kempf VAJ; Vehreschild MJGT; Serve H; Scheich S; Steffen B
    Ann Hematol; 2021 Jun; 100(6):1593-1602. PubMed ID: 33942127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Single Center Analysis of Bloodstream Infection Clinical Characteristics and Prognosis in Patients with Hematological Malignancies in the Tropics].
    Cheng LC; Yang T; Kuang HH; Yu S; Guan LX; Gu ZY; Xu YY; Zheng WS; Wang L; Hu YL; Gao XN; Wang QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):265-271. PubMed ID: 33554832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
    Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors for Mortality in Hematopoietic Stem Cell Transplantation Recipients with Bloodstream Infection: Points To Be Addressed by Future Guidelines.
    Puerta-Alcalde P; Chumbita M; Charry P; Castaño-Díez S; Cardozo C; Moreno-García E; Marco F; Suárez-Lledó M; Garcia-Pouton N; Morata L; Fernández-Avilés F; Martínez-Roca A; Rodríguez G; Martínez JA; Martínez C; Mensa J; Urbano Á; Rovira M; Soriano A; Garcia-Vidal C
    Transplant Cell Ther; 2021 Jun; 27(6):501.e1-501.e6. PubMed ID: 33891882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacteremia in patients with hematological malignancies.
    Wang FD; Lin ML; Liu CY
    Chemotherapy; 2005 May; 51(2-3):147-53. PubMed ID: 15886475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bloodstream infections in cancer patients. Risk factors associated with mortality.
    Islas-Muñoz B; Volkow-Fernández P; Ibanes-Gutiérrez C; Villamar-Ramírez A; Vilar-Compte D; Cornejo-Juárez P
    Int J Infect Dis; 2018 Jun; 71():59-64. PubMed ID: 29649549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial profile and antimicrobial susceptibility patterns in cancer patients.
    Worku M; Belay G; Tigabu A
    PLoS One; 2022; 17(4):e0266919. PubMed ID: 35427384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
    Cordero L; Rau R; Taylor D; Ayers LW
    Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.